Acarbose primarily inhibits α-glucosidase enzymes and diminishes and slows down the
intestinal carbohydrate breakdown for absorption from polysaccharides to disaccharides
and from disaccharides to monosaccharide.
1
,
2
Case reports and double-blinded clinical trials have shown acarbose is effective
in preventing postprandial hypoglycemia in patients with reactive hypoglycemia
3
,
4
,
5
with most cases being after gastric surgery. Thus far, there has been only one case
report
3
published on the use of acarbose that examined the relation between GLP-1 secretion
and insulin-glucose dynamics. It showed
3
an increase in the glucose nadir when ingesting sucrose with acarbose, with postprandial
glucose and insulin peaks being blunted and parallel reductions in GLP-1 responses.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the American Medical Directors AssociationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Management of elderly diabetic patients in the subacute care setting.Clin Geriatr Med. 2000; 16: 833-852
- Update on diabetes in the elderly and the application of current therapeutics.J Am Med Dir Assoc. 2007; 8: 489-492
- Reactive hypoglycemia due to late dumping syndrome: Successful treatment with acarbose.Swiss Med Wkly. 2001; 131: 81-83
- Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycemia after gastric surgery.Gut. 1983; 24: 798-802
- Acarbose in reactive hypoglycemia: A double-blind study.Int J Clin Pharmacol Ther Toxicol. 1984; 22: 25-31
- Voglibose (AO-128) is an efficient α-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve.Digestion. 1995; 56: 493-501
- Prolonged and enhanced secretion of glucagon-like peptide 1 (7–36 amide) after oral sucrose due to α-glucosidase inhibition (acarbose) in type 2 diabetic patients.Diabet Med. 1998; 15: 485-491
- The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.Diabetes Obes Metab. 2002; 4: 329-335
Article info
Identification
Copyright
© 2010 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.